"Dana-Farber provides expert clinical care with Brigham and Women's Hospital and Boston Children's Hospital, and is a teaching affiliate of Harvard Medical School," its website said. The Dana-Farber Cancer Institute was founded in 1947. Likewise, the cancer institute's partnership for pediatric cancer care with Boston Children's Hospital will not change.īeth Israel Lahey Health will also continue to invest in advancing cancer services at Beth Israel Deaconess Medical Center and at its other hospitals. Outpatient oncology care at Dana-Farber's existing locations in Boston, Chestnut Hill and other regional campuses will not be interrupted. ![]() Located adjacent to existing Dana-Farber and Beth Israel facilities in Longwood, the proposed new cancer hospital will support both seamless patient care and continued focus on research initiatives, the release said. It will also create flexibility to incorporate the innovations and technology in cancer care that Dana-Farber and Beth Israel researchers and clinicians are developing. The state-of-the-art inpatient hospital will increase adult patient capacity. The Boston Globe reported: "Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center have announced plans to build a new free-standing inpatient hospital for adult cancer care in Boston, breaking the cancer hospital's almost 30-year relationship with Brigham and Women's in a move executives said will reshape oncology care in the region."ĭana Farber said that at a time when the population is aging, cancer incidence is rising in younger adults and severity of illness is increasing, a forward-looking model maximizes the patient benefits of advanced technologies and treatment methods by accelerating the impact of discovery and innovation. This will continue through the transition, Dana-Farber said.īeth Israel's independent oncology programs will also continue until the new collaboration is in place. Pending regulatory approvals, it will take several years to implement the cancer collaboration and construct the new cancer hospital, according to the release.ĭana-Farber has long been affiliated with Brigham and Women's Hospital in Boston for inpatient and surgical care. Together, Dana-Farber and Beth Israel, with its affiliated physician group Harvard Medical Faculty Physicians, will establish a coordinated clinical and organizational structure for oncology care in the Longwood Medical Area of Boston. The proposed state-of-the-art inpatient cancer hospital will operate under the license of Dana-Farber and provide adult medical oncology care. ![]() The collaboration focuses exclusively on cancer care.Įach organization will remain fully independent, including their executive leadership, boards of trustees and philanthropy, while leveraging the expertise and research of both institutions. ![]() The Dana-Farber Beth Israel Deaconess Cancer Collaboration is designed to transform the future patient experience by improving access, by better integrating innovations at the bedside and by offering high-value care, Dana-Farber said. Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center in Boston have announced plans to collaborate on cancer care and build an independent, free-standing inpatient hospital for adult cancer patients.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |